81
60
Growth Score
-6 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
480094
Cypher Genomics is providing automated genome interpretation of next generation sequencing data for diagnostics development and biomarkers.
Acquired by 
Human Longevity
About the Company
Cypher Genomics is a genome informatics company that develops and delivers automated human genome interpretation software solutions for clinical labs, pharmaceutical companies, and population genomics efforts.
Their automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' sensitivity and specificity
profiles to develop molecular tests for diagnostic and prognostic use and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies.
Cypher Genomics was founded by Ashley Van Zeeland in 2011 and is headquartered in La Jolla, California. It is now acquired by Human Longevity.
